CombiMatrix Reports Q3 Sales Decline, Considers Strategic Options for Future | GenomeWeb

This story was originally published on Nov. 12.

By Justin Petrone

CombiMatrix CEO Amit Kumar last week said talks with "potential suitors" for strategic deals — which may include the sale of the company or its businesses — are "progressing," and the firm is ready to evaluate offers from interested parties.

He made his comments during a conference call to discuss the firm’s third-quarter earnings report, which showed that revenues fell slightly and net loss narrowed by a quarter.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.